Korean Drug Co., Ltd. (KOSDAQ: 014570)

Korean Drug Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,053	11,689	3,426	4,841	7,068	6,271
Short-Term Investments	9,966	5,067	22,990	-	-	-
Trading Asset Securities	-	-	-	23,039	15,162	5,255
Cash & Short-Term Investments	18,018	16,756	26,416	27,881	22,230	11,526
Cash Growth	-46.62%	-36.57%	-5.25%	25.42%	92.87%	33.69%
Accounts Receivable	27,014	27,854	31,196	28,501	27,880	28,040
Other Receivables	128.86	154.04	264.21	481.69	13.67	40.26
Receivables	27,143	28,008	31,460	28,983	27,894	28,080
Inventory	21,257	18,341	13,775	12,894	10,744	11,839
Prepaid Expenses	14.73	29.68	15.8	14.88	12.11	10.9
Other Current Assets	840.61	291.26	949.19	677.81	2,075	1,271
Total Current Assets	67,273	63,426	72,617	70,450	62,956	52,727
Property, Plant & Equipment	22,571	22,999	18,607	13,999	13,784	14,849
Long-Term Investments	219.79	261.49	363.89	1,353	2,610	4,714
Other Intangible Assets	275.07	362.8	490.55	263.02	672.79	650.11
Long-Term Accounts Receivable	-	-	-	-	-	-0
Long-Term Deferred Tax Assets	939.43	1,015	1,163	820.32	307.16	-
Other Long-Term Assets	1,157	1,645	1,276	1,728	3,015	2,909
Total Assets	92,436	89,709	94,516	88,613	83,345	75,850
Accounts Payable	3,485	1,921	4.55	3,213	2,662	3,066
Accrued Expenses	1,930	1,951	1,896	1,131	974.24	760.84
Current Portion of Leases	63.47	51.31	59.47	39.07	45.85	54.28
Current Income Taxes Payable	1,629	2,192	1,499	2,151	1,788	548.75
Other Current Liabilities	4,174	3,786	3,953	3,796	4,301	4,147
Total Current Liabilities	11,283	9,902	7,412	10,329	9,771	8,577
Long-Term Leases	14.47	16.26	21.73	15	6.16	25.88
Long-Term Deferred Tax Liabilities	-	-	-	-	-	10.93
Other Long-Term Liabilities	2,285	2,355	2,107	1,579	2,697	2,186
Total Liabilities	14,754	12,619	9,804	11,923	12,474	10,800
Common Stock	5,500	5,500	5,500	5,500	5,500	5,500
Additional Paid-In Capital	3,430	3,430	3,431	3,430	3,419	3,413
Retained Earnings	70,295	69,724	77,364	69,345	62,488	56,636
Treasury Stock	-1,543	-1,563	-1,583	-1,586	-536.16	-499.33
Comprensive Income & Other	-0	-0	-0	0	0	0
Shareholders' Equity	77,682	77,090	84,713	76,690	70,871	65,050
Total Liabilities & Equity	92,436	89,709	94,516	88,613	83,345	75,850
Total Debt	77.94	67.57	81.2	54.07	52.01	80.17
Net Cash (Debt)	17,940	16,688	26,335	27,826	22,178	11,446
Net Cash Growth	-46.75%	-36.63%	-5.36%	25.47%	93.77%	32.76%
Net Cash Per Share	1665.74	1547.64	2441.99	2548.06	2040.10	1048.97
Filing Date Shares Outstanding	10.79	10.79	10.78	10.78	10.89	10.89
Total Common Shares Outstanding	10.79	10.79	10.78	10.78	10.89	10.89
Working Capital	55,990	53,524	65,205	60,121	53,184	44,150
Book Value Per Share	7199.81	7146.81	7855.42	7111.75	6507.00	5970.82
Tangible Book Value	77,407	76,727	84,222	76,427	70,198	64,400
Tangible Book Value Per Share	7174.32	7113.17	7809.93	7087.35	6445.23	5911.15
Land	7,681	7,681	7,681	5,748	5,748	5,748
Buildings	7,013	14,955	11,264	11,264	11,006	11,006
Machinery	6,152	9,974	7,215	7,387	6,845	6,635
Construction In Progress	231	969.41	3,376	-	3.6	410.13

Source: S&P Capital IQ. Standard template. Financial Sources.